Issue of Equity

RNS Number : 1272U
Futura Medical PLC
08 October 2010
 



 

For immediate release

8 October 2010

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

Issuance of Shares Following Employee Option Exercise

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, has applied for 160,000 new ordinary shares of 0.2p each in the Company to be admitted to trading on AIM. The shares are being issued following the exercise of options.

The shares will rank pari passu with existing ordinary shares and dealings are expected to commence in the new ordinary shares at 8.00am on 12 October 2010. Pursuant to AIM Rules, the Company's total issued share capital following the anticipated admission of the shares as set out above is 67,643,311.

 

 

For any further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

 

 

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 

Nomura Code Securities Limited

 

Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200

 

 

For media enquiries please contact:

 

 

 

Buchanan Communications

 

Mark Court / George Prassas

Tel: +44 (0) 20 7466 5000

 

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFSIFIAFSSESS
UK 100

Latest directors dealings